Shumei Kato

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Shumei Kato

Mar 31, 2025, 14:52 | Blog

Razelle Kurzrock: Toll-like receptor 3 - a double-edged sword

Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, shared a post on X:…

Feb 7, 2025, 14:14 | Insight

The need for personalized, patient-centered, biomarker-based approaches to oncology clinical trials

CA: A Cancer Journal for Clinicians shared a post on X about a paper by…

Aug 8, 2024, 01:57 | Opinion

Razelle Kurzrock: Outstanding work from our precision immunotherapy team and collaborators

Razelle Kurzrock shared a post by Yuji Uehara, Medical Oncologist at National Cancer Center Hospital…

Jul 10, 2024, 01:26 | Blog

Razelle Kurzrock: Rare and ultra-rare cancers - large unmet need

Razelle Kurzrock shared a post on X: ''Rare and ultra-rare cancers are large unmet need.…

May 18, 2024, 13:04 | Insight

Jacob Adashek: Thinking outside the box

Jacob Adashek, Medical oncology fellow at the Sidney Kimmel Comprehensive Cancer Center at the Johns…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023